德英生物科技
News

News

  • Medical teams from Sri Lanka and Southeast Asia visited our company for a tour and business discussions.

    2019.07.30

    Events
    Medical teams from Sri Lanka and Southeast Asia visited our company for a tour and business discussions.
  • 【Announcement】Congratulations! Chairman 郭國華 Elected as Executive Director and Vice Chairman of the Taiwan Biotechnology Industry

    2019.04.01

    Media
    【Announcement】Congratulations! Chairman 郭國華 Elected as Executive Director and Vice Chairman of the Taiwan Biotechnology Industry
  • Former DPP Chairman 施明德 and 陳嘉君, Chairman of the 施明德 Cultural Foundation, along with his spouse, visited for an on-site tour

    2019.03.07

    Media
    Former DPP Chairman 施明德 and 陳嘉君, Chairman of the 施明德 Cultural Foundation, along with his spouse, visited for an on-site tour
  • [Announcement] Our company’s food factory has been approved by the Ministry of Health and Welfare for PIC/S GMP certification, a

    2019.02.21

    Events
    [Announcement] Our company’s food factory has been approved by the Ministry of Health and Welfare for PIC/S GMP certification, a
  • PIC/S GMP and GDP Factory Inspection Application

    2018.08.08

    Events
    PIC/S GMP and GDP Factory Inspection Application
  • Announcement Statement (August 1, Year 107)

    2018.08.01

    Media
    Announcement Statement (August 1, Year 107)
  • Attending the North American Biotechnology Industry Exhibition (BIO) in Boston, USA.

    2018.07.10

    Events
    Attending the North American Biotechnology Industry Exhibition (BIO) in Boston, USA.
  • Thanks to TVBS for visiting and interviewing for the program "World is Turning Upside Down."

    2017.08.28

    Events
    Thanks to TVBS for visiting and interviewing for the program "World is Turning Upside Down."
  • D&E Biotech SR-T100 New Drug Unblinding Investor Presentation on March 29, 2016

    2016.03.29

    Events
    D&E Biotech SR-T100 New Drug Unblinding Investor Presentation on March 29, 2016
  • The company's Corporate Governance Evaluation result for the 103rd fiscal year was ranked in the top 20% of TPEx-listed comp

    2015.05.04

    Events
    The company's Corporate Governance Evaluation result for the 103rd fiscal year was ranked in the top 20% of TPEx-listed comp
  • The Company will participate in the investor forum held by Grand Cathay Securities on March 28, 2014.

    2014.03.28

    Events
    The Company will participate in the investor forum held by Grand Cathay Securities on March 28, 2014.
  • Company Receives U.S. Approval for Skin Aging and Inflammation Therapy

    2013.11.08

    Wellness Insights
    Company Receives U.S. Approval for Skin Aging and Inflammation Therapy